Mignogna, Jolanda (2016) A clinical evaluation of the efficacy of a new hemostatic device for topical use in the surgical management of patients undergoing anticoagulant therapy. [Tesi di dottorato]

[img]
Preview
Text
Jolanda Mignogna finale .pdf

Download (1MB) | Preview
[error in script] [error in script]
Item Type: Tesi di dottorato
Lingua: English
Title: A clinical evaluation of the efficacy of a new hemostatic device for topical use in the surgical management of patients undergoing anticoagulant therapy
Creators:
CreatorsEmail
Mignogna, Jolandajolandamignogna@gmail.com
Date: 30 March 2016
Number of Pages: 48
Institution: Università degli Studi di Napoli Federico II
Department: Neuroscienze e Scienze Riproduttive ed Odontostomatologiche
Scuola di dottorato: Medicina clinica e sperimentale
Dottorato: Scienze odontostomatologiche
Ciclo di dottorato: 28
Coordinatore del Corso di dottorato:
nomeemail
Rengo, Sandrosanrengo@unina.it
Tutor:
nomeemail
Sammartino, GilbertoUNSPECIFIED
Date: 30 March 2016
Number of Pages: 48
Uncontrolled Keywords: emostasi, terapia anticoagulante
Settori scientifico-disciplinari del MIUR: Area 06 - Scienze mediche > MED/28 - Malattie odontostomatologiche
Date Deposited: 11 Apr 2016 22:05
Last Modified: 07 Nov 2016 08:43
URI: http://www.fedoa.unina.it/id/eprint/10719

Abstract

In oral surgery, the management of patients on anticoagulant therapy is still challenging because of the risk of uncontrolled bleeding and, if the therapy is discontinued, the possibility of undesired thromboembolic complications. The use of local hemostatic agents may be a viable alternative to overcome such problems. Pursuing this line, the aim of this randomized clinical trial was to evaluate the use of newly developed swelling matricx loaded with tranexamic acid to prevent postextractive bleeding in patients with no modification of oral anticoagulant therapy. The matrix is able to fit the tridimensional postexctractive alveolar cavity, thus assuring also a mechanical contribution to homeostasis. The potential of this new therapeutic approach for reducing hospitalization, removing the risk of infections, and lowering the number of hemorrhagic complications was demonstrated.

Actions (login required)

View Item View Item